Delivery Order SPE2DB22D2006-SPE2DB24FW2VY
Award Date
8/12/24
Potential Completion Date
8/13/24
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, is a delivery order worth $21,347.00 for the supply of 4564938215 IPOL VIAL 5ML. The award was made by the Defense Logistics Agency, a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,805.52 firm-fixed-price delivery order contract is for the supply of IPOL VIAL 5ML, a pharmaceutical product. The contract has an ultimate completion date of June 12, 2025. Amerisourcebergen Drug Corp is not designated as a set-aside contractor for this award. Amerisourcebergen Drug Corp...
This federal contract award, valued at $16,010.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564856969 IPOL VIAL 5ML, a pharmaceutical product, with a completion date of June 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $11,119.02 firm-fixed-price delivery order is for the supply of 4567327713 IPOL VIAL 5ML medical products, with a final completion date of February 21, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,149.56 firm fixed-price delivery order is for the supply of IPOL VIAL 5ML medical products, with a period of performance through May 23, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,561.52 Firm Fixed Price Delivery Order is for the supply of IPOL VIAL 5ML medical products. Amerisourcebergen has a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
This federal contract award, valued at $2,616.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4568028291 IPOL VIAL 5ML, with a period of performance through April 28, 2025. This award is not associated with any set-aside program and represents an open competition contract. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,486.05 firm fixed-price delivery order is for IPOL VIAL 5ML medical products. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of pharmaceutical products and medical supplies, including IPOL VIAL 5ML, to support various government agencies and healthcare programs. The contract, with a ceiling value of $1,067.35, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of August 13, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $103,895.16 firm fixed-price delivery order is for the supply of 4568733802 IPOL VIAL 5ML medical products. The contract has an ultimate completion date of July 9, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...